Gisondi, P.; Loconsole, F.; Raimondo, P.; Ravasio, R. Cost Per Responder for Risankizumab Vs Secukinumab in Patients With Moderate-to-Severe Plaque Psoriasis in Italy. Grhta 2021, 8, 120-130.